Key result
A 39-year-old man with acute aortic valve regurgitation due to isolated myxoid degeneration was successfully treated with a bioprosthetic aortic valve replacement and had an uneventful clinical course at 1 year.
Why the study?
Myxoid degeneration of the aortic valve is an uncommon cause of acute aortic valve regurgitation in young individuals.
Case Report (n=1)
No
Isolated myxoid degeneration of the aortic valve is an uncommon cause of acute severe aortic regurgitation in young patients that can mimic endocarditis or cardiac sarcoidosis.
Recognize myxoid degeneration in young patients with acute AR; leaves open optimal management and durability data.
Myxoid degeneration of the aortic valve as a cause of acute aortic valve regurgitation in young age is uncommon. We report a 39-year-old African-American man with a history of epilepsy and hypertension who presented with a 1-month history of worsening shortness of breath. He was diagnosed with acute pulmonary oedema. Transoesophageal echocardiogram showed normal ejection fraction but severe aortic valve insufficiency with small masses on the ventricular side of the right and non-coronary cusps, small vegetations cannot be ruled out but other valves were normal. Subsequent cultures were negative for endocarditis. Myocardial positron emission tomography (PET) scan was strongly suggestive of cardiac sarcoidosis. However, this diagnosis was ruled out as well when he underwent aortic valve replacement with bioprosthetic valve as he did not want to take long-term anticoagulation. Histological examination of the aortic valve showed myxoid degeneration. The patient was doing very well 1 year after the surgery.
No takes yet. Share an insight, caveat, or question.
Kyi et al. (2019) conducted a case report in Acute aortic valve regurgitation due to myxoid degeneration (n=1). Aortic valve replacement with bioprosthetic valve was evaluated on Clinical outcome at 1 year. A 39-year-old man with acute aortic valve regurgitation due to isolated myxoid degeneration was successfully treated with a bioprosthetic aortic valve replacement and had an uneventful clinical course at 1 year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: